Amanda Rush/LinkedIn
Dec 22, 2025, 22:34
Amanda Rush and Other Researchers Spoke with 87 Australians Affected by a Range of Blood Disorders
Haemophilia Foundation Australia shared a post on LinkedIn:
“Gene therapies are creating new hope for people with serious conditions like haemophilia. These treatments can be life-changing, but they also raise important questions: how should we pay for them, who should have access, and what happens when the long-term effects are still uncertain?
In the latest issue of National Haemophilia, Amanda Rush and other researchers spoke with 87 Australians affected by a range of blood disorders as part of a study led by the University of Sydney.
Thanks to the people and parents of children with haemophilia who participated in this research.
Read the results.”

Stay informed with latest blood disorders updates on Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
